Options for fi­nancing and optimizing medicines in resource-poor countries

Background Paper, 34

Overview

The paper  has four broad sections. Section-1 discusses the challenges to medicines’ financing in developing countries and highlights  some of the bottlenecks  in medicines availability, affordability, and the lack of good regulation and planning. The following  section analyses different  options for financing medicines  and their merits and  demerits. Section-3 brings out some  examples of successful execution of the listed financing options. Section-4 provides an analytical framework for financing to attain universal coverage of medicines. 

This report is part of a series, The World Health Report 2010 Background Papers, which were written to inform the process of developing the key messages of the World Health Report 2010: Health systems financing: The path to universal coverage.

 

WHO Team
Health Financing (HEF)